Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Clinical Trials

Promentis Pharmaceuticals Commences Phase 1 Study For SXC-2023 Targeting Neuropsychiatric Disorders

Clinical Trials
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a Phase 1 single ascending...

Sobi begins phase 3 study evaluating safety and efficacy of anakinra to treat Still’s disease

Clinical Trials
Swedish Orphan Biovitrum AB (Sobi) has announced that the first patient has been randomised in the phase 3 study anaSTILLs, to evaluate efficacy and...

Abivax Enrolls First Ulcerative Colitis Patient In New ABX464 Proof-Of-Concept Clinical Trial

Clinical Trials
ABIVAX announced the enrolment of the first patient in the ABX464-101 proof-of-concept study of its lead product candidate ABX464 in subjects suffering from moderate-to-severe...

Wellthy Therapeutics conducts first made-in-India ‘digital pill’ clinical trial for diabetes

Clinical Trials
Wellthy Therapeutics a digital therapeutics company that uses artificial intelligence (AI) and patient centric design to improve patient outcomes is now conducting the first...

Webflow Mobile App Launch

Americas
WebflowTM is a comprehensive customer support center which provides PCI clients real-time, 24/7 access to a wide range of reports and information regarding the...

TRACON Pharmaceuticals Announces Positive Results from Phase 1 Trial of TRC102 and Fludara® in Patients with Advanced Hematologic Malignancy Published in Oncotarget

Clinical Trials
TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration...

Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease

Clinical Trials
New data presented showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.